19 results match your criteria: "National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases[Affiliation]"
J Endocr Soc
January 2023
Section of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Front Endocrinol (Lausanne)
May 2022
Department of Medicine, State University of Midwest (UNICENTRO), Guarapuava, Brazil.
J Endocr Soc
May 2022
Section of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia 20010, USA.
Context: Recombinant human thyrotropin (rhTSH) is currently not Food and Drug Administration approved for the treatment of high-risk patients with differentiated thyroid cancer (DTC).
Objective: The goal of our study was to compare the outcomes in higher-risk patients with metastatic DTC prepared for radioiodine (RAI) therapy with rhTSH vs thyroid hormone withdrawal (THW).
Methods: A retrospective chart review was performed of patients with metastatic DTC in follow-up at MedStar Washington Hospital Center and MedStar Georgetown University Hospital from 2009 to 2017.
Front Endocrinol (Lausanne)
February 2021
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK), Bethesda, MD, United States.
Thyroid ultrasound (US), fine needle aspiration biopsy (FNAB), and molecular testing have been widely used to stratify the risk of malignancy in thyroid nodules. The goal of this study was to investigate a novel diagnostic approach for cytologically indeterminate thyroid nodules (ITN) based upon a combination of US features and genetic alterations. We performed a pilot cohort study of patients with ITN (Bethesda III/IV), who underwent surgical treatment.
View Article and Find Full Text PDFAm J Gastroenterol
November 2019
Division of GI and Liver Diseases, University of Southern California, Los Angeles, California, USA.
Introduction: Patients with hepatitis B early antigen (HBeAg)-negative chronic hepatitis B (CHB) and low-level viremia are a heterogeneous group. Identifying those at risk of developing active CHB requiring antiviral therapy is important. In this study, we prospectively characterize incidence rates and predictors of transitioning from inactive to active CHB in a North American adult cohort.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
March 2016
Program in Nutritional Metabolism (M.T., S.S., K.V.F., K.W., E.P., S.K.G.) and Division of Musculoskeletal Imaging and Intervention (M.T.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; Section on Integrative Physiology and Metabolism (T.T., C.R.K., A.M.C.), Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts 02215; and Translational Physiology Section, Diabetes, Endocrinology, and Obesity Branch, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (A.M.C.), Bethesda, Maryland 20892.
Context: HIV patients are at an increased risk for cardiometabolic disease secondary to depot-specific alterations in adipose function, but mechanisms remain poorly understood.
Objective: The endoribonuclease Dicer has been linked to the modulation of brown and white adipocyte differentiation. We previously demonstrated that Dicer knockout mice undergo transformation of brown adipose tissue to white adipose tissue and develop a lipodystrophic phenotype.
Clin Diabetes
October 2015
Departments of Medicine and Epidemiology, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD ; Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD.
In Brief This article reports on an investigation of whether an intensive lifestyle intervention (ILI) would reduce gastrointestinal symptoms over 4 years of follow-up for participants in the Action for Health in Diabetes (Look AHEAD) trial compared to a diabetes support and education (DSE) group. Look AHEAD is a randomized, multicenter trial comparing overweight and obese adults with type 2 diabetes treated with ILI versus DSE. ILI, and weight loss in general, had beneficial effects on gastrointestinal (GI) symptoms, with some variability in the strength of the effect depending on the specific symptom and time course.
View Article and Find Full Text PDFDis Mon
May 2015
University of Maryland Medical Center (Department of Medicine, Division of Gastroenterology and Hepatology), Baltimore, Maryland; National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases), Bethesda, Maryland; Veterans Affairs Maryland Health Center System (Veterans Affairs), Baltimore, Maryland.
Pseudomembranous colitis is an inflammatory condition of the colon characterized by elevated yellow-white plaques that coalesce to form pseudomembranes on the mucosa. Patients with the condition commonly present with abdominal pain, diarrhea, fever, and leukocytosis. Because pseudomembranous colitis is often associated with infection, stool testing and empiric antibiotic treatment should be initiated when suspected.
View Article and Find Full Text PDFClin J Am Soc Nephrol
May 2015
National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona
Significant advances are needed to improve the diagnosis, prognosis, and management of persons with CKD. Discovery of new biomarkers and improvements in currently available biomarkers for CKD hold great promise to achieve these necessary advances. Interest in identification and evaluation of biomarkers for CKD has increased substantially over the past decade.
View Article and Find Full Text PDFLancet Diabetes Endocrinol
October 2014
University of Alabama at Birmingham, AL, USA.
Lancet Diabetes Endocrinol
October 2014
University of Alabama at Birmingham, AL, USA.
Psychosom Med
January 2014
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases/Obesity and Diabetes Clinical Research Section, 4212 North 16th St, Room 541, Phoenix, AZ 85016.
Objective: Ghrelin, a peptide hormone secreted mainly by the stomach, increases appetite and food intake. Surprisingly, ghrelin levels are lower in obese individuals with binge eating disorder (BED) than in obese non-BED individuals. Acute psychological stress has been shown to raise ghrelin levels in animals and humans.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
December 2013
MD, Obesity and Diabetes Clinical Research Section, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, 4212 North 16th Street (Fifth Floor), Phoenix, AZ 85016.
Context: Human brown adipose tissue (BAT) is activated with cold exposure, but it is unknown whether overfeeding activates BAT.
Objective: We determined BAT activation with cold, fasting, and overfeeding and the relationship of BAT activation with future weight change.
Design, Setting, Participants, And Interventions: Sixteen healthy adults were evaluated during energy balance, fasting, and 24 hours of 200% overfeeding.
Diabetologia
September 2013
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, 445 North 5th Street, Phoenix, AZ 85004, USA.
Aims/hypothesis: MicroRNAs (miRNAs) are short endogenous RNAs that regulate multiple biological processes including adipogenesis and fat metabolism. We sought to identify miRNAs that correlate with BMI and to elucidate their upstream regulation and downstream targets.
Methods: Microarray-based expression profiling of 233 miRNAs was performed on subcutaneous abdominal adipose tissue biopsies from 29 non-diabetic Pima Indian participants.
J Clin Endocrinol Metab
March 2011
Obesity and Diabetes Clinical Research Section, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases/Department of Health and Human Services, 4212 North 16th Street, Phoenix, Arizona 85016, USA.
Context: Peripheral and central endocannabinoids and cognate acylethanolamides (AEs) may play important but distinct roles in regulating energy balance.
Objective: We hypothesized that in humans central/peripheral endocannabinoids are differently associated with adiposity and energy expenditure and differ by race.
Design: We examined associations of arachindonoylethanolamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleoylethanolamide (OEA) assayed in plasma and cerebrospinal fluid (CSF) with race, adiposity, and energy expenditure.
J Clin Endocrinol Metab
January 2006
Digestive National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases/Digestive Diseases Branch, Bethesda, Maryland 20892-1804, USA.
Context: Multiple endocrine neoplasia type 1 (MEN1) patients frequently develop Zollinger-Ellison syndrome (MEN1/ZES). Although esophageal reflux symptoms are common in these patients, little is known about long-term occurrence of severe peptic esophageal disease including strictures and Barrett's esophagus (BE).
Objective: The objective of the study was to prospectively analyze the frequency of severe peptic esophageal disease in ZES patients with and without MEN1.
J Clin Endocrinol Metab
December 2002
Clinical Diabetes and Nutrition Section, National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona 85016, USA.
Prader-Willi syndrome (PWS) is a genetic disorder occurring in 1 of 10,000-16,000 live births and is characterized by excessive appetite with progressive massive obesity as well as short stature and mental retardation. Most patients have GH deficiency and hypogonadotropic hypogonadism. The causes of the hyperphagia and abnormal GH secretion are unknown.
View Article and Find Full Text PDF